Acologix Inc., of Emeryville, Calif., appointed Tom Smart to its board.
ActivBiotics Inc., of Lexington, Mass., appointed Andrew Sternlicht vice president of clinical development.
Albany Molecular Research Inc., of Albany, N.Y., named Michael Trova senior vice president of chemistry. It also promoted Bruce Sargent to vice president of discovery research and development, Patricia Ellis to vice president of quality and regulatory affairs and Barbara Galbiati to director of analytical quality services. Kenton Shultis assumed the added responsibility for the company's cGMP synthesis and manufacturing efforts.
Alexza Molecular Delivery Corp., of Palo Alto, Calif., appointed Jeffrey Williams senior vice president of corporate and business development.
Ambrx Inc., of San Diego, appointed John Wallen vice president of intellectual property.
Amgen Inc., of Thousand Oaks, Calif., named Rodger Currie vice president of government affairs.
Anadys Pharmaceuticals Inc., of San Diego, promoted Michael Kamdar to senior vice president of corporate development and finance.
AspenBio Inc., of Castle Rock, Colo., appointed Douglas Helper to its board.
AXM Pharma Inc., of Newport Beach, Calif., hired Hao Zhang as vice president of marketing.
BioStratum Inc., of Research Triangle Park, N.C., named Kirk Ways vice president and chief development officer.
BioTrove Inc., of Woburn, Mass., appointed Patrick Caroll chief business officer.
BioVest International Inc., of Worcester, Mass., appointed Jeffrey Scott, Robert Weiss, Christopher Chapman and Nicholas Leb to its board.
Celera Genomics Group, of Rockville, Md., appointed Paulette Dillon chief business officer.
Coley Pharmaceuticals Group Inc., of Wellesley, Mass., appointed Charles Abdalian senior vice president of finance and chief financial officer.
Protein Polymer Technologies Inc., of San Diego, appointed Donald Kaplan president and chief operating officer.
Questcor Pharmaceuticals Inc., of Union City, Calif., appointed Neal Bradsher to the board.
Serenex Inc., of Durham, N.C., appointed Elizabeth Wyatt to its board.
Sucampo Pharmaceuticals Inc., of Bethesda, Md., appointed Michael Jeffries, George Lasezkay and Hidetoshi Mine to its board.
TaiGen Biotechnology Co. Ltd., of Taipei, Taiwan, appointed John Cheng chief financial officer.
Tanox Inc., of Houston, appointed Peter Traber to its board.
TolerRx Inc., of Cambridge, Mass., appointed Ian Smith to its board.
Vertex Pharmaceuticals Inc., of Cambridge, Mass., appointed Paul Anderson to the scientific advisory board.
Vicuron Pharmaceuticals Inc., of King of Prussia, Pa., appointed Jennifer Copeland and Steven Gelone senior directors of the medical science liaison field force.
Watson Pharmaceuticals Inc., of Corona, Calif., appointed Catherine Klema to its board.
Xanodyne Pharmaceuticals Inc., of Florence, Ky., appointed Stephen Stamp chief financial officer.
Xcellerex LLC, of Marlborough, Mass., appointed Susan Dexter chief business officer of contract manufacturing.
YM BioSciences Inc., of Mississauga, Ontario, appointed John Friedman to its board.